Journal «Angiology and Vascular Surgery» • 

2009 • VOLUME 15 • №1

TRANSLUMINAL BALLOON ANGIOPLASTY IN TREATMENT OF LOWER LIMB CRITICAL ISCHAEMIA

Kaputin M.Yu., Ovcharenko D.V., Soroka V.V., Borovskii I.E., Dudanov I.P., Beregovskii V.B.
Department ofRoentgenosurgicalMethods of Diagnosis and Treatment St. Petersburg Scientific Research Institute of Emergency Ambulance Care named after I.I. Dzhanelidze,
St. Petersburg, Russia

Objective of the study: To evaluate efficiency of translumi-nal balloon angioplasty (TLBAP) in treatment of lower limb critical ischaemia (LLCI).

Materials and methods: Over the period from November 2004 to April 2008, we performed a total of 89 TLBAPs in eighty-two patients presenting with LLCI. The patients’ age averagely amounted to 67.8±9.8 years. Fifty (61%) patients had an ischaemic ulcer on the foot, seventeen (20.7%) had gangrene, and fifteen (18.3%) patients suffered from ischaemic pain at rest. Forty-five (54.9%) patients suffered from diabetes mellitus, including thirty-three (40.2%) subjects with insulin dependent DM. Sixty (73.2%) patients were diagnosed as having coronary heart disease (CHD), sixty-five (79.3%) had arterial hypertension, twenty-five (30.5%) – cerebrovascular disease, and thirteen (15.9%) – chronic renal insufficiency. Six (7.3%) patients were on chronic haemodialysis. The distribution of the patients by the level of the lesion were as follows: iliac 4 (3.6%), femoropopliteal 55 (49.5%), crural artery 52 (46.8%) Type-C and type-D lesions (TASC) were encountered in 89.2% of cases. Occlusions were observed in 82% of all lesions of the crural artery. 42.2% of the patients were treated by means of subintimal angioplasty. Stenting was used in fourteen (7.3%) cases.

Results: The angiographic and clinical success of the procedure was achieved in seventy-five (91.5%) patients. No LLCI was observed either after one or three years in 79.4 and 52.9% of the patients, respectively.

KEY WORDS: transluminal balloon angioplasty, lower limb critical ischaemia.

P. 142-147

« Back

Angiologia.ru - portal for professionals
VLAANT
Lancet
HI-TECHNOLOGY MEDICINE